These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15803168)

  • 1. Conjunctival ischaemia subsequent to posterior subtenon's triamcinolone acetonide injection.
    Rubinstein A; Hanson RJ; Chen SD; Porter N; Downes SM
    Eye (Lond); 2006 Mar; 20(3):388-9. PubMed ID: 15803168
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent triamcinolone acetonide particles on the posterior lens capsule after intravitreal injection.
    Sakalar YB; Unlu K; Keklikci U; Caca I; Senol BB
    Ann Ophthalmol (Skokie); 2008; 40(3-4):190-2. PubMed ID: 19230363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjunctival ulceration following triamcinolone injection.
    Agrawal S; Agrawal J; Agrawal TP
    Am J Ophthalmol; 2003 Sep; 136(3):539-40. PubMed ID: 12967811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid-induced ptosis: case studies and histopathologic analysis.
    Song A; Carter KD; Nerad JA; Boldt C; Folk J
    Eye (Lond); 2008 Apr; 22(4):491-5. PubMed ID: 17220825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtenon's depot corticosteroid injections in patients with a history of corticosteroid-induced intraocular pressure elevation.
    Levin DS; Han DP; Dev S; Wirostko WJ; Mieler WF; Connor TB; George V; Eastwood D
    Am J Ophthalmol; 2002 Feb; 133(2):196-202. PubMed ID: 11812422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex keratitis after intravitreal triamcinolone acetonide.
    Shtein RM; Stahl RM; Saxe SJ; Mian SI
    Cornea; 2007 Jun; 26(5):641-2. PubMed ID: 17525670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.
    Audren F; Erginay A; Haouchine B; Benosman R; Conrath J; Bergmann JF; Gaudric A; Massin P
    Acta Ophthalmol Scand; 2006 Oct; 84(5):624-30. PubMed ID: 16965492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
    Veritti D; Lanzetta P; Perissin L; Bandello F
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2391-7. PubMed ID: 19117937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide.
    Quiram PA; Gonzales CR; Schwartz SD
    Am J Ophthalmol; 2006 Mar; 141(3):580-2. PubMed ID: 16490518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years.
    Islam MS; Vernon SA; Negi A
    Eye (Lond); 2007 Mar; 21(3):321-3. PubMed ID: 16543927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Pizzimenti JJ; Nickerson MM; Pizzimenti CE; Kasten-Aker AG
    Optom Vis Sci; 2006 Jul; 83(7):421-5. PubMed ID: 16840867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravitreal triamcinolone for diabetic macular oedema. Method and complications].
    Zamfir C
    Oftalmologia; 2009; 53(1):100-5. PubMed ID: 19569613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
    Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
    Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Objective evaluation of cataract progression associated with a high dose intravitreal triamcinolone injection.
    Chu YK; Chung EJ; Kwon OW; Lee JH; Koh HJ
    Eye (Lond); 2008 Jul; 22(7):895-9. PubMed ID: 17435692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a single intraoperative sub-Tenon injection of triamcinolone acetonide on the progression of diabetic retinopathy and visual outcomes after cataract surgery.
    Kim SY; Yang J; Lee YC; Park YH
    J Cataract Refract Surg; 2008 May; 34(5):823-6. PubMed ID: 18471640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Full-thickness macular hole in a patient with diabetic cystoid macular oedema treated by intravitreal triamcinolone injections.
    Lecleire-Collet A; Offret O; Gaucher D; Audren F; Haouchine B; Massin P
    Acta Ophthalmol Scand; 2007 Nov; 85(7):795-8. PubMed ID: 17459030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial.
    Bonini-Filho MA; Jorge R; Barbosa JC; Calucci D; Cardillo JA; Costa RA
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3845-9. PubMed ID: 16186372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.